Skip to main navigation
Audentes TherapeuticsAudentes TherapeuticsAudentes TherapeuticsAudentes TherapeuticsAudentes TherapeuticsAudentes Therapeutics
  • Who We Are
  • Our Approach
  • Innovative Therapies
    • Overview
    • X-Linked Myotubular Myopathy
    • Crigler-Najjar Syndrome
    • Pompe Disease
    • CASQ2-related Catecholaminergic Polymorphic Ventricular Tachycardia
  • Patients + Families
    • Welcome
    • Will’s Story
    • Emi’s Story
    • Isabella’s Story
    • Expanded Access Policy
  • Careers
  • Investor + Media
    • Overview
    • Press Releases
    • Events & Presentations
      • Upcoming Events
      • Past Events
    • Corporate Goverance
      • Documents & Charters
      • Committee Composition
    • Stock Information
      • Stock Quote and Chart
      • Historical Price Lookup
    • Annual Reports & Proxy
    • SEC Filings
    • Analyst Coverage
    • E-mail Alerts
    • Investor Contact
  • Who We Are
  • Our Approach
  • Innovative Therapies
    • Overview
    • X-Linked Myotubular Myopathy
    • Crigler-Najjar Syndrome
    • Pompe Disease
    • CASQ2-related Catecholaminergic Polymorphic Ventricular Tachycardia
  • Patients + Families
    • Welcome
    • Will’s Story
    • Emi’s Story
    • Isabella’s Story
    • Expanded Access Policy
  • Careers
  • Investor + Media
    • Overview
    • Press Releases
    • Events & Presentations
      • Upcoming Events
      • Past Events
    • Corporate Goverance
      • Documents & Charters
      • Committee Composition
    • Stock Information
      • Stock Quote and Chart
      • Historical Price Lookup
    • Annual Reports & Proxy
    • SEC Filings
    • E-mail Alerts
    • Investor Contact
Investors + Media
Investors + Media

Upcoming Events

Upcoming Events

  • Audentes Therapeutics at the Cowen 39th Annual Health Care Conference

    Tuesday, March 12, 2019 11:20 AM EDT
    Click here for webcast
    Add to Outlook
    Add to Google Calendar
  • Audentes Therapeutics at the 8th Annual SVB Leerink Global Healthcare Conference

    Thursday, February 28, 2019 9:30 AM EST
    Click here for webcast
    Add to Outlook
    Add to Google Calendar

Investor Toolkit

  • Print Page
  • RSS Feeds
  • E-mail Alerts


Investors + Media

Investors + Media

  • Overview
  • Press Releases
  • Events & Presentations
    • Upcoming Events
    • Past Events
  • Corporate Governance
  • Stock Information
  • Annual Reports & Proxy
  • SEC Filings
  • Analyst Coverage
  • E-mail Alerts
  • Investor Contact
  • Who We Are
  • Our Approach

Innovative Therapies

  • Overview
  • X-Linked Myotubular Myopathy
  • Crigler-Najjar Syndrome
  • Pompe Disease
  • CASQ2-related Catecholaminergic Polymorphic Ventricular Tachycardia

PATIENTS + FAMILIES

  • Welcome
  • Will’s Story
  • Emi’s Story
  • Isabella’s Story
  • Expanded Access Policy
  • Careers
  • Investors + Media
  • Contact

Audentes Therapeutics, Inc.

600 California Street, 17th Floor
San Francisco, CA 94108

Phone: (415) 818-1001

Email: info@audentestx.com

© Copyright Audentes Therapeutics. Terms and Conditions | Privacy Statement
FacebookTwitterLinkedin